Copyright Reports & Markets. All rights reserved.

Global Bio-based L-Valine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bio-based L-Valine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity: 96%-98%
    • 1.3.3 Purity: ＞98%
  • 1.4 Market Analysis by Raw Material Source
    • 1.4.1 Overview: Global Bio-based L-Valine Consumption Value by Raw Material Source: 2021 Versus 2025 Versus 2032
    • 1.4.2 Food Crop-based
    • 1.4.3 Non-food Biomass-based
    • 1.4.4 Waste-derived
  • 1.5 Market Analysis by Purity Grade
    • 1.5.1 Overview: Global Bio-based L-Valine Consumption Value by Purity Grade: 2021 Versus 2025 Versus 2032
    • 1.5.2 Feed Grade
    • 1.5.3 Food Grade
    • 1.5.4 Pharmaceutical Grade
  • 1.6 Market Analysis by Production Route
    • 1.6.1 Overview: Global Bio-based L-Valine Consumption Value by Production Route: 2021 Versus 2025 Versus 2032
    • 1.6.2 Microbial Fermentation Method
    • 1.6.3 Enzyme-catalyzed Method
    • 1.6.4 Metabolic Engineering Modification Route
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Bio-based L-Valine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Feed
    • 1.7.3 Health Supplements
    • 1.7.4 Pharmaceutical
    • 1.7.5 Others
  • 1.8 Global Bio-based L-Valine Market Size & Forecast
    • 1.8.1 Global Bio-based L-Valine Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Bio-based L-Valine Sales Quantity (2021-2032)
    • 1.8.3 Global Bio-based L-Valine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 CJ Group
    • 2.1.1 CJ Group Details
    • 2.1.2 CJ Group Major Business
    • 2.1.3 CJ Group Bio-based L-Valine Product and Services
    • 2.1.4 CJ Group Bio-based L-Valine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 CJ Group Recent Developments/Updates
  • 2.2 Anhui Huaheng Biotechnology Co.,Ltd.
    • 2.2.1 Anhui Huaheng Biotechnology Co.,Ltd. Details
    • 2.2.2 Anhui Huaheng Biotechnology Co.,Ltd. Major Business
    • 2.2.3 Anhui Huaheng Biotechnology Co.,Ltd. Bio-based L-Valine Product and Services
    • 2.2.4 Anhui Huaheng Biotechnology Co.,Ltd. Bio-based L-Valine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Anhui Huaheng Biotechnology Co.,Ltd. Recent Developments/Updates
  • 2.3 Evonik Industries
    • 2.3.1 Evonik Industries Details
    • 2.3.2 Evonik Industries Major Business
    • 2.3.3 Evonik Industries Bio-based L-Valine Product and Services
    • 2.3.4 Evonik Industries Bio-based L-Valine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Evonik Industries Recent Developments/Updates
  • 2.4 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd.
    • 2.4.1 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Details
    • 2.4.2 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Major Business
    • 2.4.3 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Bio-based L-Valine Product and Services
    • 2.4.4 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Bio-based L-Valine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Bio-based L-Valine by Manufacturer

  • 3.1 Global Bio-based L-Valine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Bio-based L-Valine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Bio-based L-Valine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Bio-based L-Valine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Bio-based L-Valine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Bio-based L-Valine Manufacturer Market Share in 2025
  • 3.5 Bio-based L-Valine Market: Overall Company Footprint Analysis
    • 3.5.1 Bio-based L-Valine Market: Region Footprint
    • 3.5.2 Bio-based L-Valine Market: Company Product Type Footprint
    • 3.5.3 Bio-based L-Valine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bio-based L-Valine Market Size by Region
    • 4.1.1 Global Bio-based L-Valine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Bio-based L-Valine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Bio-based L-Valine Average Price by Region (2021-2032)
  • 4.2 North America Bio-based L-Valine Consumption Value (2021-2032)
  • 4.3 Europe Bio-based L-Valine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Bio-based L-Valine Consumption Value (2021-2032)
  • 4.5 South America Bio-based L-Valine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Bio-based L-Valine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Bio-based L-Valine Sales Quantity by Type (2021-2032)
  • 5.2 Global Bio-based L-Valine Consumption Value by Type (2021-2032)
  • 5.3 Global Bio-based L-Valine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Bio-based L-Valine Sales Quantity by Application (2021-2032)
  • 6.2 Global Bio-based L-Valine Consumption Value by Application (2021-2032)
  • 6.3 Global Bio-based L-Valine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Bio-based L-Valine Sales Quantity by Type (2021-2032)
  • 7.2 North America Bio-based L-Valine Sales Quantity by Application (2021-2032)
  • 7.3 North America Bio-based L-Valine Market Size by Country
    • 7.3.1 North America Bio-based L-Valine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Bio-based L-Valine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Bio-based L-Valine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Bio-based L-Valine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Bio-based L-Valine Market Size by Country
    • 8.3.1 Europe Bio-based L-Valine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Bio-based L-Valine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bio-based L-Valine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Bio-based L-Valine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Bio-based L-Valine Market Size by Region
    • 9.3.1 Asia-Pacific Bio-based L-Valine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Bio-based L-Valine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Bio-based L-Valine Sales Quantity by Type (2021-2032)
  • 10.2 South America Bio-based L-Valine Sales Quantity by Application (2021-2032)
  • 10.3 South America Bio-based L-Valine Market Size by Country
    • 10.3.1 South America Bio-based L-Valine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Bio-based L-Valine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bio-based L-Valine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Bio-based L-Valine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Bio-based L-Valine Market Size by Country
    • 11.3.1 Middle East & Africa Bio-based L-Valine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Bio-based L-Valine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Bio-based L-Valine Market Drivers
  • 12.2 Bio-based L-Valine Market Restraints
  • 12.3 Bio-based L-Valine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bio-based L-Valine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bio-based L-Valine
  • 13.3 Bio-based L-Valine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bio-based L-Valine Typical Distributors
  • 14.3 Bio-based L-Valine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Bio-based L-Valine market size was valued at US$ 60.50 million in 2025 and is forecast to a readjusted size of US$ 117 million by 2032 with a CAGR of 10.1% during review period.
    In 2025, global production of bio-based L-valine was approximately 14,000 metric tons, with an average global market price of around $4,200 per metric ton. That year, total global production capacity for bio-based L-valine reached 22,000 metric tons, and the industry's average gross profit margin stood at 28%. Bio-based L-valine refers to L-valine products manufactured from renewable biomass resources using green production processes such as microbial fermentation and biotransformation. L-valine is an essential branched-chain amino acid (BCAA) for humans and a crucial component of protein synthesis; since the human body cannot synthesize it internally, it must be obtained through food, nutritional supplements, or pharmaceutical products. Compared to traditional chemical synthesis routes, bio-based L-valine is produced via the fermentation of engineered strains using renewable carbon sources—such as glucose, corn starch, and sugarcane molasses—offering advantages such as sustainable raw material sourcing, a lower environmental footprint, high product purity, and excellent chiral selectivity.
    The upstream segment of the bio-based L-valine industry chain primarily encompasses the supply of renewable carbon sources, the R&D of fermentation strains, and the provision of auxiliary materials for biomanufacturing. Key raw materials include corn starch, sugarcane, cassava, and wheat starch; these are converted into glucose through saccharification to serve as the carbon source for microbial fermentation. Current industrial production predominantly utilizes engineered strains such as *Corynebacterium glutamicum*, employing metabolic engineering to enhance the valine synthesis pathway and improve yield and conversion efficiency. Core upstream technologies focus on high-yield strain screening, genetic engineering optimization, fermentation process control, and the improvement of raw material utilization efficiency. Additionally, factors such as nitrogen sources, inorganic salts, culture medium components, and fermentation equipment significantly influence production costs. The midstream segment primarily involves biological fermentation, separation and extraction, purification and crystallization, drying and packaging, and quality testing. During production, microorganisms synthesize L-valine from carbohydrate-based raw materials, and high-purity products are obtained through processes including fermentation broth filtration, centrifugation, membrane separation, ion exchange, concentration/crystallization, and drying. Depending on downstream demand, midstream products are typically categorized into various specifications, such as feed-grade, food-grade, pharmaceutical-grade, and research-grade. Among these, feed-grade L-valine emphasizes cost control and large-scale supply, whereas food-grade and pharmaceutical-grade products are subject to stricter requirements regarding purity, microbiological standards, impurity control, and production certifications. Current industry competition focuses on increasing fermentation yields, reducing energy consumption, enhancing production automation, and developing product systems characterized by high purity and stability. Downstream applications for bio-based L-valine are primarily concentrated in the sectors of animal nutrition, food nutrition, sports and health, and pharmaceuticals. The feed industry represents one of the largest markets; as a limiting amino acid, L-valine is widely used in swine, poultry, and aquaculture to balance amino acid profiles in feed, improve protein utilization efficiency, and reduce feed costs. Demand for functional amino acids like L-valine continues to rise alongside the large-scale expansion of the global livestock industry and the adoption of low-protein diet technologies. In human nutrition, L-valine—a key branched-chain amino acid—is extensively used in sports nutrition supplements, functional foods, and nutritional formulations. In the pharmaceutical and biotechnology sectors, L-valine is utilized in amino acid infusions, cell culture media, biopharmaceutical manufacturing processes, and related scientific research applications.
    As a key branched-chain amino acid (BCAA), bio-based L-valine plays a vital role in animal protein synthesis and nutritional metabolism. In the feed industry, it is primarily used to optimize low-protein diet formulations, enhance feed utilization efficiency, and reduce farming costs. Driven by rising global meat consumption, the intensification of livestock farming, and stricter environmental regulations regarding nitrogen emissions, there is growing interest in precision feed formulation and amino acid balancing technologies, fueling a steady increase in demand for functional amino acids like L-valine. Compared to traditional high-protein feed models, the addition of crystalline amino acids reduces the reliance on protein-rich raw materials and boosts farming efficiency; this approach represents a key trend in the modern feed industry and ensures stable, foundational demand for bio-based L-valine.
    Beyond animal feed, L-valine holds significant value in human nutrition. As an essential amino acid for the human body, it is widely used in sports nutrition supplements, functional foods, and nutritional formulations. The market for BCAAs continues to expand—driven by a shift toward health-conscious consumption, a growing fitness-oriented population, and rising demand for specialized nutrition—leading to an increased need for high-purity, food-grade L-valine. Furthermore, in the pharmaceutical and life sciences sectors, L-valine is utilized in amino acid preparations, cell culture media, biopharmaceutical manufacturing processes, and scientific research reagents. Looking ahead, the advancement of the biopharmaceutical industry and cell culture technologies positions high-purity and pharmaceutical-grade L-valine as key drivers of value creation within the sector.
    Currently, bio-based L-valine is primarily produced via microbial fermentation, with core competitiveness centered on high-yield strain development, metabolic engineering optimization, fermentation process control, and separation and purification technologies. Future industry efforts will focus on engineering genetically modified strains to improve glucose conversion efficiency and unit yields, while simultaneously reducing production costs through continuous fermentation, intelligent control systems, and energy-efficient processes. Additionally, the use of non-food biomass, agricultural waste, and low-carbon sugar sources as alternatives to traditional raw materials is emerging as a crucial trend in green manufacturing, helping to lower carbon emissions and enhance the sustainability of the industry value chain. Companies possessing independent strain R&D capabilities and large-scale fermentation capacity will secure a distinct competitive advantage in the future market.
    Report Scope
    This report is a detailed and comprehensive analysis for global Bio-based L-Valine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Bio-based L-Valine market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Bio-based L-Valine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Bio-based L-Valine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Bio-based L-Valine market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bio-based L-Valine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bio-based L-Valine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CJ Group, Anhui Huaheng Biotechnology Co.,Ltd., Evonik Industries, Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Bio-based L-Valine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market Segmentation
    Market segment by Type
    Purity: 96%-98%
    Purity: ＞98%
    Market segment by Raw Material Source
    Food Crop-based
    Non-food Biomass-based
    Waste-derived
    Market segment by Purity Grade
    Feed Grade
    Food Grade
    Pharmaceutical Grade
    Market segment by Production Route
    Microbial Fermentation Method
    Enzyme-catalyzed Method
    Metabolic Engineering Modification Route
    Market segment by Application
    Feed
    Health Supplements
    Pharmaceutical
    Others
    Major players covered
    CJ Group
    Anhui Huaheng Biotechnology Co.,Ltd.
    Evonik Industries
    Jinyao Ruida (Xuchang) BIOLOGY Technology Co., Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe Bio-based L-Valine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Bio-based L-Valine, with price, sales quantity, revenue, and global market share of Bio-based L-Valine from 2021 to 2026.
    Chapter 3, the Bio-based L-Valine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Bio-based L-Valine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Bio-based L-Valine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Bio-based L-Valine.
    Chapter 14 and 15, to describe Bio-based L-Valine sales channel, distributors, customers, research findings and conclusion.

    Buy now